William Hu 胡旭波
William Hu is a managing partner of Qiming Venture Partners. William co-leads Qiming’s practice in healthcare sector and has been closely involved with more than 30 new ventures, some of which have become public or billion dollar market cap companies. On behalf of Qiming, he invested in Tigermed(SZ: 300347), BBI Lifescience (HK: 01035), Tellgen(SZ: 300642), AmoyDx(SZ: 300685), Rendu Bio, ET Healthcare, Vinno Medical, APT Medical, Sanyou Orthopedic, Canbridge, Ark Bio, Connect Pharma, Antengene, Centreherbs, Arrail Dental, WeDoctor, Medsci, Bang’Er orthopedics Hospitals, ShuLan Hospital, Qiangsen healthcare, and etc.
William holds Bachelor of Medicine from Shanghai Medical University and MBA from ENPC SH Campus.